XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.

Clinical trial NCT06792435 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06792435
Sponsor: Astellas Pharma Global Development, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Metastatic Lung Cancer (NSCLC)Ovarian Cancer Colorectal Cancer Metastatic Biliary Tract Cancer Gastric Carcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2023-07-27
Primary completion: 2026-12-30
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.